MIRA INFORM REPORT

 

 

Report Date :

02.01.2014

 

IDENTIFICATION DETAILS

 

Name :

ASTEC LIFESCIENCES LIMITED 

 

 

Registered Office :

Elite Square, 7th Floor, 274, Perin Nariman Street, Fort, Mumbai – 400 001, Maharashtra 

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

25.01.1994

 

 

Com. Reg. No.:

11-076236

 

 

Capital Investment / Paid-up Capital :

Rs.180.441 millions

 

 

CIN No.:

[Company Identification No.]

L99999MH1994PLC076236

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMA20370A

 

 

PAN No.:

[Permanent Account No.]

AAACA4832D

 

 

Legal Form :

Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturing of Agro and Pharma Chemicals.

 

 

No. of Employees :

105 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (47)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 4279000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a satisfactory track record.

 

The company has seen an improvement in its performance marked by better increase in its sales volume as well as net profitability during 2013.

 

The ratings also take into consideration the decent financial profile marked by healthy capital structure influenced by equity infusion by the promoters.

 

Trade relations are fair. Business is active. Payment terms are reported as usually correct.

 

In view of long standing experience and expertise of the promoters, the subject can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2013

 

Country Name

Previous Rating

(30.06.2013)

Current Rating

(30.09.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India’s current account deficit narrowed in the quarter ended September as government measures to curb imports, especially gold, kicked in.  The current account deficit, the excess of a country’s imports of goods and services over exports, narrowed to $ 5.2 billion from $ 21 billion in the year ago period, according to provisional Reserve Bank of India data. Finance Minister P. Chidambaram said the CAD for the year will be less than $ 60 billion or 3 per cent of GDP and the latest data suggests the government may achieve the target.

 

India was ranked 94th among the world’s most corrupt nations list. Denmark and New Zealand topped as the cleanest while Somalia emerged as the most corrupt.

 

India’s services sector activity witnessed a moderate improvement in November over the previous month, even while indicating the fifth successive monthly contraction, according the HSBC survey.

 

$53 million estimated losses suffered by India due to phishing attacks during the third quarter, according to a study by RSA. India ranks fourth in the list of nations hit by phishing attacks. The US remained at the top of the charts. Phishing is the process of acquiring information such as user names, passwords and credit card details by sending e-mails disguised as official mails.

 

Rs.4080 million worth of mobile-phone-based transactions by July 2013 compared to Rs.260 million in September, 2012, according to Deloitte report. The number of transactions has shot up from 94000 to 701000.

 

India aims to earn Rs.400000 million from the bandwidth auction set for January. The merger and acquisition guidelines, cleared by a group of ministers, will be out before the auction begins so that players can make informed decisions on the auctions.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Term Loans: BBB-

Rating Explanation

Moderate degree of safety and moderate credit risk.

Date

April, 2013

 

 

Rating Agency Name

ICRA

Rating

Short Term, Non-Fund Based Limits: A3

Rating Explanation

Moderate degree of safety and higher credit risk.

Date

April, 2013

 

 

RBI DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAILTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

LOCATIONS

 

Registered Office/ Corporate Office :

Elite Square, 7th Floor, 274, Perin Nariman Street, Fort, Mumbai – 400 001, Maharashtra, India

Tel No.:

91-22-22618212

Mobile No.:

91-9920689888  (Mr. Vijay Jain)

Fax No.:

91-22-22618289

E-Mail :

nikita@astecls.com

ah@astecls.com

javedsyed@astecls.com

vikas@astecls.com

info@astecls.com

ravendra@astecls.com

Website :

www.astecls.com

www.asteclifesciences.com

 

 

Research and Development Center :

F-39, MIDC, Phase-II, Dombivali (East), Thane – 421 204, Maharashtra, India

Location :

Owned

 

 

Factory 1 :

B-17, B-18 and B-21, MIDC Mahad, Birwadi Industrial Area, Mahad, District Raigad – 413 341, Maharashtra, India

 

 

Factory 2 :

B-16, MIDC Mahad, Birwadi Industrial Area, Local Unit Mahad, District Raigad – 413 341, Maharashtra, India

 

 

Factory 3 :

Additional MIDC, Plot No.K-2/1/1, Mahad, District Raigad – 413 341, Maharashtra, India

 

 

DIRECTORS

 

AS ON 31.03.2013

 

Name :

Mr. Ashok Vishwanath Hiremath

Designation :

Chairman and Managing Director

Address :

3, Jai Kiran, 35, Cuffe Parade, Colaba, Mumbai – 400 005, Maharashtra, India

Date of Birth/Age :

31.05.1955

Date of Appointment :

01.02.1994

 

 

Name :

Mr. Janak J. Rawal

Designation :

Whole Time Director (Appointed w.e.f. 20.01.2012)

 

 

Name :

Dr. P. L. Tiwari

Designation :

Non-Executive – Non Independent Director

Date of Birth/Age :

01.07.1945

Qualification :

MBBS, MD

Date of Appointment :

25.01.1994

 

 

Name :

Mr. Laxmikant Ramprasad Kabra

Designation :

Non-Executive – Non Independent Director

Date of Birth/Age :

09.03.1969

Qualification :

B.com, F.C.A

Expertise in specific Functional Area :

Mr. Laxmikant Kabra, is an eminent Chartered Accountant. He has over 23 years of experience in the fields of Income Tax, Company Law, Banking, Finance etc. During his tenure he has worked with Ficom Organics Limited and

Rishiroop Rubber International Limited for two years each after which he started his own practice as a Chartered Accountant in Mumbai under the firm name Laxmikant Kabra and Company.

Date of Appointment :

25.01.1994

 

 

Name :

Prof. Vinod Malshe

Designation :

Non-Executive – Independent Director

Date of Birth/Age :

28.02.1947

Qualification :

Master of Science (Technology)

Date of Appointment :

28.03.2008

 

 

Name :

Mr. Sitendu Sharma

Designation :

Non-Executive – Independent Director

 

 

Name :

Mr. Mohammed Zakir

Designation :

Non-Executive – Independent Director

 

 

Name :

Mr. Mandar Kamlakar Patil

Designation :

Non-Executive – Independent Director

Date of Birth/Age :

24.05.1970

Qualification :

B.Com, F.C.A

Expertise in specific Functional Area :

Mr. Mandar Kamlakar Patil is a Chartered Accountant in Practice for over 19 Years. He is practicing from Thane and is specialized in Statutory Audits, Direct Taxation and Indirect Taxation. He is the major contributor to the Company in the field of taxation.

Date of Appointment :

27.05.2012

 

 

 

KEY EXECUTIVES

 

Name :

Ms. Tejal Jariwala

Designation :

Company Secretary and Compliance Officer

 

 

Name :

Mr. Ravindra Inani

Designation :

Chief Financial Officer

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2013

 

Category of Shareholders

 

No. of Shares

Percentage of Holding

(A) Shareholding of Promoter and Promoter Group

 

 

(1) Indian

 

 

Individuals / Hindu Undivided Family

8162880

44.05

Bodies Corporate

943000

5.09

Any Others (Specify)

1651100

8.91

Directors/Promoters & their Relatives & Friends

1651100

8.91

Sub Total

10756980

58.05

(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

10756980

58.05

(B) Public Shareholding

 

 

(1) Institutions

 

 

(2) Non-Institutions

 

 

Bodies Corporate

2801687

15.12

Individuals

 

 

Individual shareholders holding nominal share capital up to Rs.0.100 million

3098546

16.72

Individual shareholders holding nominal share capital in excess of Rs.0.100 million

1756480

9.48

Any Others (Specify)

115437

0.62

Clearing Members

7164

0.04

Non Resident Indians

108273

0.58

Sub Total

7772150

41.95

Total Public shareholding (B)

7772150

41.95

Total (A)+(B)

18529130

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

0

0.00

(1) Promoter and Promoter Group

0

0.00

(2) Public

0

0.00

Sub Total

0

0.00

Total (A)+(B)+(C)

18529130

0.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of Agro and Pharma Chemicals.

 

 

Products :

·         Agrochemicals

·         Intermediates

 

 

PRODUCTION STATUS (AS ON 31.03.2011):

 

Particulars

Unit

Licensed Capacity

Installed Capacity

Actual Production

Agro and Pharma Intermediates

M.T.

NA

3450.00

2992.60

 

 

GENERAL INFORMATION

 

No. of Employees :

105 (Approximately)

 

 

Bankers :

  • Axis Bank Limited, Nariman Point, Mumbai, Maharashtra, India 
  • State Bank of Hyderabad, Colaba, Mumbai, Maharashtra, India 
  • IDBI Bank Limited, Cuffe Parade, Mumbai, Maharashtra, India 

 

 

Facilities :

Secured Loans

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

LONG TERM BORROWINGS

 

 

Term loans From banks

214.555

110.820

SHORT TERM BORROWINGS

 

 

Term loans From banks

0.961

0.000

Loans repayable on demand From banks

415.718

535.191

Total

631.234

646.011

 

Notes:

 

a) Details of Guarantee for each type of borrowings

 

Particulars

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

Guaranteed by directors

 

 

Term loans

 

 

From banks

214.555

110.820

 

 

 

Loans repayable on demand

 

 

From banks

416.679

535.191

Total

631.234

646.011

 

b) Details of security for each type of borrowings

(a) Term loans from banks are secured by way of first mortgage/ charge over entire movable and immovable Fixed Assets (Present and Future) of the Company and second Pari-Passu Charge over current assets of the Company.

 

(b) Loans repayable on demand from Banks (Working Capital loans) are secured by first Pari-passu charge on the entire current assets of the Company both present and future and further secured by second pari-passu charge on entire fixed assets (Present and Future) of the Company.

 

C) Terms of repayment of term loans and other loans

Term loans (Foreign Currency) of Rs.165.462 millions (Previous year Rs.101.580 millions) having an interest rate of 7.25% are repayable in 8 semi annual installments commencing from 1st July, 2013.

 

Term Loan of Rs.9.176 millions (Previous Year Rs.13.810 millions) having interest rate of 15% are repayable in Quarterly Installments of Rs.1.132 millions each. Last Installment due on 31st March, 2015. Installments falling due in respect of all the above loans upto 31.03.2014 have been regrouped under Current Maturities of Long Term debt.

 

Term Loan of Rs.50.000 millions (Sanctioned Rs.100.000 millions) (Previous Year Nil) having interest rate of BBR Plus 300bps which is 13.25% are repayable in 18 Quarterly equal Installments of Rs.5.556 millions each. Last Installment due on 31st March, 2018. Installments falling due in respect of all the above loans upto 31.03.2014 have been regrouped under Current Maturities of Long Term debt.

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

P.M. Kathariya and Company

Chartered Accountants

Address :

Mumbai, Maharashtra, India

 

 

Cost Auditors :

Ritesh N. Talathi and Company

Cost Accountants

 

 

Internal Auditors :

P. S. V. Jain and Associates

Chartered Accountants

 

 

Subsidiaries :

·         Behram Chemicals Private Limited

·         Astec Crop Care Private Limited

·         Astec Europe SPRL

·         Comercializadora Agricola

·         Agroastrachem Cia Ltda at Columbia

 

 

Associates :

·         Opus Chemicals Private Limited

·         GreenGuard Technologies Private Limited

·         India TL Domain Private Limited

·         Altimax Financial Services Private Limited

·         Sahbhagi Financial Services Private Limited

 

 

CAPITAL STRUCTURE

 

AS ON 17.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

20000000

Equity Shares

Rs.10/- each

Rs.200.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

18529130

Equity Shares

Rs.10/- each

Rs.185.291 millions

 

 

 

 

 

AS ON 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

20000000

Equity Shares

Rs.10/- each

Rs.200.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

18044130

Equity Shares

Rs.10/- each

Rs.180.441 millions

 

 

 

 

 

a) Reconciliation of share capital (Equity)

 

Particulars

No. of Shares

Amount

(Rs. in Millions)

Balance at the beginning of the year

16929130

169.291

Add : Issued during the year

1115000

11.150

Balance at the end of the year

18044130

180.441

 

b) Shareholders holding more than 5% of the average shares in the company’s Equity Shares

 

Name of Shareholder

No. of Shares

Amount

(Rs. in Millions)

Ashok V. Hiremath

6115780

61.158

Suresh Hiremath

1650000

16.500

Dr. P. L. Tiwari

1650000

16.500

Hridaynath Consultancy Private Limited

1054849

10.548

Total

10470629

104.706

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

EQUITY AND LIABILITIES

 

 

 

(1) Shareholders' Funds

 

 

 

(a) Share Capital

180.441

169.291

169.291

(b) Reserves & Surplus

885.212

814.735

800.393

(c) Money received against share warrants

4.123

13.600

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

1069.776

997.626

969.684

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

214.555

110.820

21.206

(b) Deferred tax liabilities (Net)

38.567

27.580

24.129

(c) Other long term liabilities

263.572

218.292

34.251

(d) Long-term provisions

4.289

0.738

7.835

Total Non-current Liabilities (3)

520.983

357.430

87.421

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

445.120

559.279

378.755

(b) Trade payables

454.665

295.174

228.287

(c) Other current liabilities

59.613

45.768

48.578

(d) Short-term provisions

27.900

13.384

9.838

Total Current Liabilities (4)

987.298

913.605

665.458

 

 

 

 

TOTAL

2578.057

2268.661

1722.563

 

 

 

 

ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1201.563

755.418

719.861

(ii) Intangible Assets

0.438

0.330

0.000

(iii) Capital work-in-progress

130.716

436.206

89.948

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

9.981

9.881

9.757

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

78.741

31.487

11.146

(e) Other Non-current assets

0.000

0.000

0.545

Total Non-Current Assets

1421.439

1233.322

831.257

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.243

117.382

78.772

(b) Inventories

441.125

433.230

353.480

(c) Trade receivables

601.354

307.302

342.526

(d) Cash and cash equivalents

43.024

35.408

30.090

(e) Short-term loans and advances

70.872

142.017

86.438

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

1156.618

1035.339

891.306

 

 

 

 

TOTAL

2578.057

2268.661

1722.563

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Revenue from operations (Net)

1656.575

1108.406

1111.251

 

 

Other Income

14.375

10.189

10.280

 

 

TOTAL                                     (A)

1670.950

1118.595

1121.531

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

1087.212

780.078

691.756

 

 

Purchase of traded goods

0.000

69.699

184.538

 

 

Changes in inventories of finished goods, work-in-progress and traded goods

31.242

(82.386)

(46.252)

 

 

Employee benefit expenses

79.223

47.479

39.265

 

 

Other Expenses

188.681

129.699

82.734

 

 

Duties and Taxes/ Prior Period Items

9.492

1.411

(0.218)

 

 

TOTAL                                     (B)

1395.850

945.980

951.823

 

 

 

 

 

Less

PROFIT / (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

275.100

172.615

169.708

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

70.322

53.429

40.354

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

204.778

119.186

129.354

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

117.321

84.754

57.732

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX (E-F)                 (G)

87.457

34.432

71.622

 

 

 

 

 

Less

TAX                                                                  (H)

28.012

10.252

20.779

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX (G-H)                  (I)

59.445

24.180

50.843

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Exports at FOB

770.100

384.400

251.000

 

TOTAL EARNINGS

770.100

384.400

251.000

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

772.900

301.800

155.578

 

 

Capital Goods

0.000

1.200

0.000

 

TOTAL IMPORTS

772.900

303.000

155.578

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

 

 

 

 

- Basic

3.45

1.43

3.00

 

- Diluted

3.43

1.43

3.00

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

3.56

2.16

4.53

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

5.28

3.11

6.45

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

3.59

1.89

4.41

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.08

0.03

0.07

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.62

0.67

0.42

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.17

1.13

1.34

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

Unsecured Loans

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

SHORT TERM BORROWINGS

 

 

Loans and advances from related parties

17.136

12.802

Loans repayable on demand from other

parties

11.305

11.286

Total

28.441

24.088

 

 

 

 

FINANCIAL RESULTS:

 

The year 2012-13 has been one of turnaround for the Company, against the backdrop of prior period legacy challenges. During the year, the Company focused on its key markets for driving its business growth; the Company improved its product mix and capitalized on product level opportunities opening up on regulatory approvals coming about; at the same time, the Company continued to pursue product registrations for enhanced market growth. The company has identified contract manufacturing as a platform for future growth. For the year ending 31st March, 2013, Operating Profit i.e. EBITDA is of the order of Rs.275.099 millions, as against Operating Profit of Rs.172.615 millions in the preceding year 2011-12. Profit after Tax is Rs.59.445 millions for the year 2012-13, compared to Profit after Tax of Rs.24.181 millions reported for 2011-12.

 

MANAGEMENT DISCUSSION AND ANALYSIS

 

Business Environment

The Agro-chemicals Industry grows in tandem with the agricultural sector. Agricultural growth itself is greatly affected by monsoon, especially in the agrarian economies with large tracts of land-mass remaining uncovered with water irrigation systems. Thus, a year of good monsoon is a harbinger of growth for the agrarian economies, including Agro-chemicals Industry. Conversely, the vagaries of monsoon tend to be a spoiler for the sector.

 

As is well known, countries with large and growing population are forever under pressure for higher food produce from their limited land mass; the arable land itself is limited and getting shrunk all over the world in the wake of industrial development and urbanization. The scenario makes it imperative for the stakeholders in the agriculture space to look for and adopt new and more efficient methods of crop protection and of maximizing their yields from the given land resources under cultivation. Agro-chemicals are gaining acceptance worldwide with increasing awareness of their beneficial role in minimizing losses due to pests and thereby improving yields. For the players in the Agro-chemicals Industry, the challenge is to develop new products through research and innovation for more efficient crop protection through safe and efficient products and product applications across broad spectrum of agricultural crops in all parts of the world.

 

Global Agrochemical Industry

Globally, the standout markets are the ones in Asia, Europe and Latin America where the Agro-chemicals business has been reporting consistently high growth, riding on increasing agricultural production and strong commodity prices. Latin America at 13% is the highest growing region; Brazil happens to be the country with highest consumption of Agro-chemicals and has a market size of about US $ 9 Billion.

 

The Industry growth has been around 7-8% globally in recent years, thanks in good part to good monsoons over several years in most markets. In the year 2012, the industry witnessed a growth of 6.4% on nominal terms and 8.9% on real terms and has reached a turnover size of $ 47.3 Billion. Along with non-agricultural consumption the industry size is about 53 Billion. Global Commodity prices have been ruling firm at high levels since 2012, on the back of growing demand and the situation is unlikely to be any different in 2013, given present levels of global commodity stocks and growing demand. Going by the current scenario of continuing high prices of commodity stocks, the expectation is that 2013 would be a good year for the agrarian economies across the Globe. The Agro-chemicals Industry is likewise expected to fare well in 2013. Over the next 5 years, the Industry is expected to grow at about 5% annually, at which rate it should be a $67 Billion Industry by 2017 including non-agricultural consumption.

 

Indian Agrochemical Industry

Indian Agro-chemicals Industry is the 11th largest globally and the sixth fastest growing market across the world. However, consumption of crop protection products in India is among the lowest in the world at 0.6 kg/ha compared to 13 kg/ha in China and 7 kg/ha in US. Crop losses in India due to pest attack are about 28% among the highest in the world. There is thus a huge scope and potential for wider and intensive use of quality pesticides hand in hand with use of modern farming techniques through education and creating awareness among the farming community.

 

The Indian agricultural industry, post a poor Rabi season in the previous year, witnessed inconsistent monsoon in 2012-13, impacting farm economy across the States in North, Gujarat, Maharashtra and some parts of Karnataka. Cotton acreage fell by nearly 10% over the previous year and Paddy crop was affected due to lower water storage in dams in key states. These conditions materially affecting the Agro-chemicals Industry have been offset to some extent as a result of increased consumption of herbicides and insecticides in Soya and Pulses segments. Overall, the Industry estimated to be around 90000.000 millions achieved a modest growth of less than 5%. MNCs continue to maintain their market leadership by virtue of new molecules.

 

The overall food production is estimated to be close to 250 Million tons in 2012-13, marginally short of the record level of 252 Million tons of food production achieved in 2011-12. Government continues to permit export of wheat and other selected commodities whose stocks are far in excess of the buffer levels of storage. Sustained demand for food crops and high commodity prices for most of the crops (other than cotton) are expected to boost consumption of Agro-chemicals driving the domestic industry towards double-digit growth, under normal monsoon conditions.

 

Company’s Performance

The focus of the Company in the year 2012-13 has been on improving performance across all aspects of its business operations namely; enhance manufacturing capability and consistency in production, becoming fully compliant with environmental regulations, achieving competitiveness through efficiency in operations and enhance market presence and access leading to accelerated and profitable growth.

 

In the year 2011-12, the Company had to incur high spends on effluent treatment in order to meet the environmental regulations; it had to resort to further borrowing to address capital expenditure requirements and the infrastructure requirements for environment management.

 

The remedial measures initiated since the latter half of the year 2011-12 and carried through in the year 2012-13 have led to significant progress in the year 2012-13 in various critical areas of Company performance:

 

·         Capacity of key large volume molecules enhanced through de-bottlenecking to support higher volumes of production in peak season.

·         The overall portfolio of registrations held by the Company is 92, spread over 44 countries and in addition to it, Company has about 100 registrations to cater the Indian market.

·         The Company has identified contract manufacturing as a platform for future growth. India is well positioned to capitalize on this opportunity as multinationals are moving manufacturing from high cost western economies to India and China. India has a strong pool of scientific manpower and a well developed eco-system for the production of fine chemicals. Last year the company commenced commercial production of at its new state of the art facility at its new site at MIDC Mahad, Maharashtra (K-2). The said facility incorporates the proprietary process technology developed by their multinational major customer. Work of the second project is also completed and the commercial production has already started. The commencement of these new projects will have a substantial positive impact on the Company's agrochemical business in coming years.

 

These initiatives contributed to Production Volumes going up. During the year 2012-13 Turnover (Net) was Rs.1656.500 millions as against Rs.1108.400 millions in the year 2011-12. The export Turnover was at Rs.770.100 millions as against Rs.384.400 millions in 2011-12.

 

 

OUTLOOK

 

The Company has product offerings mainly in the segments of the crop protection Industry i.e., Fungicides, Insecticides, Herbicides. The Company’s strategy is to consolidate its presence through a few key products and access customers across the globe with a view to ensure stable performance quarter on quarter in an otherwise seasonal industry. Export volumes complement domestic sales and insulate them against vagaries and shifts in market behavior, which is not an uncommon experience in the agrochemical business. For the year 2012, it is estimated that the growth in fungicides sales, a key segment of Astec’s business, had outpaced the growth of the Industry. It is expected that this trend of higher growth of fungicides is to continue in the coming years. The initiatives taken by Astec over the preceding couple of years, more so in 2012-13 and its strategic plans going forward are expected to put the Company in a position to capitalize on this opportunity significantly in the markets of its presence.

 

The company has increased capacities of its plants. It has also implemented many cost reduction measures. In addition to this it has introduced new measures to improve its EHS performance.

 

Investment already made in additional capacities including waste water treatment facilities would make it possible to undertake treatment of higher volumes of production and reduce effluent treatment costs.

 

SUBSIDIARY OPERATIONS:

 

During the year, Company’s 100% subsidiary namely Astec Crop Care Private Limited consolidated its business of retail manufacturing of agrochemical formulations. The sales were Rs.90.600 millions in the year 2012-13 as compared to sales of Rs.33.400 millions in the preceding financial year 2011-12. Company is hopeful of achieving better performance with minimum targeted average CAGR in sales of 30% per annum over next few years. The other subsidiary companies are yet to commence any major business operations.

 

SUBSIDIARY COMPANIES:

 

The Company has following Subsidiary Companies:

 

a) Astec Crop Care Private Limited (a 100% subsidiary company) with the main object to start the business of trading in Agrochemicals and Pesticides formulation to sell in local as well as in export market with its own brand name. For the year ending 31st March, 2013, Operating Profit i.e. EBITDA is of the order of Rs.8.802 millions, as against Operating Profit/(Loss) of Rs.(7.287) millions in the preceding year 2011-12. Profit after Tax is Rs.0.368 million for the year 2012-13, compared to Loss of Rs.9.636 millions reported for 2011-12.

 

b) Behram Chemicals Private Limited is a 65.63% subsidiary of subject and has manufacturing facility at Mahad. This facility is given to subject, on lease. The Company has also foreign Subsidiary Companies primarily to pursue grant of licenses and product registrations in conformity with the local laws of the respective countries/regions.

 

c) Astec Eurpoe Sprl is 50.10 % subsidiary of their Company which is engaged in product registration activities. This company is yet to start any major commercial activity.

 

d) During the year, the Company has set-up a new subsidiary namely, Comercializadora Agricola Agroastrachem Cia Ltda in Bagota, Columbia with a main object of product registration activities. This company is yet to start any major commercial activity.

 

 

CONTINGENT LIABILITIES:

 

Particulars

 

31.03.2013

(Rs. in millions)

31.03.2012

(Rs. in millions)

Bank Guarantee Outstanding 

4.350

56.001

Letters of credit with Banks

169.233

84.477

Bills discounted but not realised 

70.913

41.799

Claims against company not acknowledged as debts in respect of sales tax demand against which company’s appeal is pending before commissioner of sales tax (Appeal)

11.649

5.302

Claims against company not acknowledged as debts in respect of Income Tax

11.247

--

 

 

UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30 SEPTEMBER, 2013 (STANDALONE)

 

(Rs. in millions)

PART 1

Sr.

No

 

Particulars

Quarter Ended

Six Month Ended

30.09.2013

30.06.2013

30.09.2013

(Unaudited)

(Unaudited)

(Unaudited)

1

Income from Operations

 

 

 

 

a) Net Sales / Income from operations (Net of Excise Duty)

585.008

416.425

1001.432

 

b) Other Operating Income

2.800

0.593

3.394

 

Total Income from Operations (net)

587.808

417.018

1004.826

2

Expenses

 

 

 

 

a) Cost of materials consumed

421.738

292.665

714.403

 

b) Purchase of stock in trade

--

--

--

 

c) Changes in inventories of finished goods and WIP

(28.373)

(28.245)

(56.618)

 

d) Employee benefits expenses

24.370

21.621

45.991

 

e) Depreciation and amortisation expenses

36.182

35.417

71.599

 

f) Other expenditure

60.771

45.391

106.162

 

Total Expenses

514.688

366.850

881.538

3

Profit/ (Loss) from operations before other income, Finance Cost and Exceptional Items (1-2)

73.121

50.168

123.289

4

Other Income

--

1.691

1.691

5

Profit / (Loss) from ordinary activities before finance cost and exceptional items (3+4)

73.121

51.859

124.979

6

Finance Costs

23.087

15.776

38.863

6A

Foreign Exchange Fluctuation ( Profit ) / Loss

10.172

6.693

16.865

7

Profit after finance costs but before Exceptional Items (5-6-6A)

39.862

29.390

69.252

8

Exceptional Items

0.278

3.173

3.451

9

Profit / (Loss) from ordinary activities before tax (7-8)

39.584

26.217

65.801

10

Tax Expense (Including deferred tax)

9.008

5.944

14.952

11

Net Profit / (Loss) from ordinary activities after tax (9-10)

30.576

20.273

50.849

12

Extra ordinary Items

--

--

--

13

Net Profit / (Loss) for the period (11 - 12)

30.576

20.273

50.849

14

Minority Interest

--

--

--

15

Net Profit / (Loss) after taxes, minority interest (13-14-15)

30.576

20.273

50.849

16

Paid-up equity share capital (Face Value Rs.10/-)

185.291

180.441

185.291

17

Reserves (excluding Revaluation Reserve)

947.700

905.484

947.700

18

Earnings per share

 

 

 

 

- Basic

1.69

1.12

2.74

 

- Diluted

1.69

1.12

2.74

 

 

 

 

 

 

PART II

 

 

 

A

PARTICULARS OF SHAREHOLDING

 

 

 

1

Public shareholding

 

 

 

 

- No of shares

7772150

7772150

7772150

 

- Percentage of shareholding

41.95%

43.07%

41.95%

2

Promoters and promoter group shareholding

 

 

 

 

a) Pledged / Encumbered

 

 

 

 

- No of shares

--

--

--

 

- Percentage of shares (as a % of the total shareholding of promoters and promoter group

--

--

--

 

- Percentage of shares (as a % of the total share capital of the company)

--

--

--

 

b) Non-encumbered

 

 

 

 

- No of shares

10756980

10271980

10756980

 

- Percentage of shares (as a % of the total shareholding of promoters and promoter group

100.00%

100.00%

100.00%

 

- Percentage of shares (as a % of the total share capital of the company)

58.05%

56.93%

58.05%

 

B

INVESTOR COMPLAINTS

 

 

 

Pending at the beginning of the quarter

0

0

 

Received during the quarter

0

1

 

Disposed of during the quarter

0

1

 

Remaining unresolved at the end of the quarter

0

0

 

Notes:

1.       The above results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting on 23.10.2013

 

2.       The company has only one reportable segment i.e. Agrochemicals and Pharma Intermediates.

 

3.       Above Financial Results includes financials results of Behram Chemicals Private Limited (65.63% subsidiary), and Astec CropCare Private Limited (100% Subsidiary of Astec). Financials of Astec Europe Sprl (50.10% subsidiary) and Comercializadora Agricola Agroastrachem Cia Ltda at Columbia (100% Subsidiary of Astec) have not been included in consolidation as there was no commercial activity during this period

 

4.       Figures of the previous period have been regrouped/rearranged, wherever necessary.

 

5.       Key standalone financial information of the company is given below:-

(Rs. in millions)

Particulars

Quarter Ended

 

Six Month Ended

30.09.2013

30.06.2013

30.09.2013

(Unaudited)

(Unaudited)

(Unaudited)

Net Sales/ Income from operations (Net of Excise Duty)

585.008

416.425

1001.432

Other Operating Income

2.800

0.593

3.394

Profit / (Loss) from ordinary activities before tax

39.584

26.217

65.801

Net Profit/ (Loss) from ordinary activities after tax

30.576

20.273

50.849

Earnings per share - Basic

1.69

1.12

2.74

Earnings per share - Diluted

1.69

1.12

2.74

 

 

FIXED ASSETS:

Tangible Assets

·         Lease Hold Land

·         Factory Building

·         Corporate Office

·         Plant and Machinery

·         Electrical Installation

·         Office Equipments

·         Furniture and Fixtures

·         Air Conditioner

·         Motor Vehicles

·         Computer

·         Flats

Intangible Assets

·          Computer Software     

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.93

UK Pound

1

Rs.102.39

Euro

1

Rs.85.12

 

 

INFORMATION DETAILS

 

Report Prepared by :

SMN


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

47

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.